MENU
DRRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

DURECT (DRRX) Ownership - Who owns DURECT?

Profile

Industry
Pharmaceuticals Other
Address
10260 Bubb Road
Phone
+1 408 777-1417
Employees
79
Web
https://www.durect.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
33.11M
P/E Ratio
N/A
Total Cash
38.99M
Projected Growth
N/A
Total Debt
23.15M
Revenue
9.19M
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
1.31
Total Debt/Equity
N/A
Revenue/Share
0.37 USD as % of share price

Fundamentals

DRRX
Capitalization
33.1M
P/E Ratio
N/A
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
39M
Total Cash/Share
1.31
Total Debt
23.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.37%
Revenue
9.19M
ROE
N/A
Book Value
14.4M
P/B Ratio
2.30
Cash Flow
N/A
Earnings
-1.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
23K
Current Ratio
1.19
Current Revenue Per Employee
22075.95
Dividends Per Share - Security
N/A
EBITDA
-33.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.11
Revenue To Assets
-59.50
Shares Held By Institutions
5.15M
Shares Outstanding - Current
29.8M
Total Liabilities
40.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
61.017
View a ticker or compare two or three
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for pain and chronic diseases

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
10260 Bubb Road
Phone
+1 408 777-1417
Employees
79
Web
https://www.durect.com